Robust and sustained immune activation in human Ebola virus infection

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 15, 2015, Pages 4518-4519

  Mandl, Judith N ^a   Feinberg, Mark B ^b  

^a MCGILL UNIVERSITY   (Canada)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTIVE IMMUNITY; ANTIBODY PRODUCTION; EBOLA HEMORRHAGIC FEVER; EBOLA VIRUS; EPIDEMIC; FEVER; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INFECTION CONTROL; INNATE IMMUNITY; MORTALITY; NONHUMAN; NOTE; PRIORITY JOURNAL; VIRUS REPLICATION; VIRUS TRANSMISSION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; EBOLAVIRUS; IMMUNOLOGY;

EBOLA VIRUS;

CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; EBOLAVIRUS; HEMORRHAGIC FEVER, EBOLA; HUMANS; IMMUNITY, CELLULAR;

EID: 84928038744     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1503864112     Document Type: Note

References (20)

1. WHO (2015) Ebola Situation Reports. Available at apps.who.int/ebola/en/current-situation/ebola-situation-report. Accessed March 19, 2015.
2. Kanapathipillai R, et al. (2014) Ebola vaccine - An urgent international priority. N Engl J Med 371(24):2249-2251.
3. Qiu X, et al. (2014) Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature 514(7520):47-53.
4. McElroy AK, et al. (2015) Human Ebola virus infection results in substantial immune activation. Proc Natl Acad Sci USA 112:4719-4724.
5. Misasi J, Sullivan NJ (2014) Camouflage and misdirection: The full-on assault of ebola virus disease. Cell 159(3):477-486.
6. Wong G, Kobinger GP, Qiu X (2014) Characterization of host immune responses in Ebola virus infections. Expert Rev Clin Immunol 10(6):781-790.
7. Mahanty S, Bray M (2004) Pathogenesis of filoviral haemorrhagic fevers. Lancet Infect Dis 4(8):487-498.
8. Zampieri CA, Sullivan NJ, Nabel GJ (2007) Immunopathology of highly virulent pathogens: insights from Ebola virus. Nat Immunol 8(11):1159-1164.
9. Bray M (2001) The role of the Type I interferon response in the resistance of mice to filovirus infection. J Gen Virol 82(Pt 6):1365-1373.
10. Villinger F, et al. (1999) Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection. J Infect Dis 179(Suppl 1):S188-S191.
11. Hutchinson KL, Rollin PE (2007) Cytokine and chemokine expression in humans infected with Sudan Ebola virus. J Infect Dis 196(Suppl 2):S357-S363.
12. Leroy EM, et al. (2000) Human asymptomatic Ebola infection and strong inflammatory response. Lancet 355(9222):2210-2215.
13. Mahanty S, et al. (2003) Protection from lethal infection is determined by innate immune responses in a mouse model of Ebola virus infection. Virology 312(2):415-424.
14. Sanchez A, et al. (2004) Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: Cellular responses, virus load, and nitric oxide levels. J Virol 78(19):10370-10377.
15. Wrammert J, et al. (2012) Rapid and massive virus-specific plasmablast responses during acute dengue virus infection in humans. J Virol 86(6):2911-2918.
16. Miller JD, et al. (2008) Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines. Immunity 28(5):710-722.
17. Dustin LB, Rice CM (2007) Flying under the radar: The immunobiology of hepatitis C. Annu Rev Immunol 25:71-99.
18. Sharpe AH, Wherry EJ, Ahmed R, Freeman GJ (2007) The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat Immunol 8(3):239-245.
19. Kreuels B, et al. (2014) A case of severe Ebola virus infection complicated by gram-negative septicemia. N Engl J Med 371(25):2394-2401.
20. Rowe AK, et al. (1999) Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis 179:(Suppl 1):S28-S35.